Sponsored
released by
Bespak
05.07.24
Drug Delivery
Editorial
-
Drug Delivery
The New Bespak: Championing Sustainability with Chris Hirst
He talks to us about key developments in the inhalation industry and how the formation of a leading global CDMO can provide support in navigating these changes.
-
Breaking News | Collaborations & Alliances | Drug Delivery | Drug Development
BioArctic, Eisai Ink Research Agreement for BAN2802 in AD
To evaluate potential new treatment combining BioArctic's BrainTransporter technology with an undisclosed Alzheimer drug candidate.04.22.24
-
Breaking News | Drug Delivery | Industry News
Bespak Separates Recipharm’s Advanced Delivery Systems BU to Form Standalone CDMO
Spin-out unites 3 sites to create a global CDMO as further significant investments are announced at Holmes Chapel site.04.02.24
-
Analytical Services | Bioanalytical Services | Drug Delivery | Laboratory Testing
Solvias: Providing Cutting-Edge Expertise in Orally Inhaled and Nasal Drug Products
A Q&A with Yannick Baschung, team leader for drug delivery and physical characterization services at Solvias.
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Delivery
Evonik, University of Mainz Partner on Drug Delivery
Aim to commercialize randomized polyethylene glycols (rPEGs), a new class of PEGs.02.20.24
-
Analytical Services | Breaking News | Drug Delivery | Industry News
Kindeva Drug Delivery Launches Analytical Services Business Unit
New state-of-the-art laboratories in Missouri will serve as the central hub for expanded suite of stand-alone analytical services.01.31.24
-
Breaking News | Drug Delivery | Industry News
Gerresheimer Expands Mfg. Ops in Peachtree City, GA
The $88 million investment will support production of medical devices, in particular autoinjectors for injectable drugs.01.22.24
-
Breaking News | Drug Delivery | Industry News
Kindeva Drug Delivery Acquires Summit Biosciences
Adds new drug-delivery platform and expands capabilities across a wider range of complex drug-device combination products.01.18.24
-
Breaking News | Drug Delivery | Industry News
FDA Approves Takeda's HYQVIA with ENHANZE Technology
Halozyme's ENHANZE drug delivery facilitates dispersion and absorption of large IG volumes subcutaneously.01.17.24
-
Breaking News | Drug Delivery | Drug Development | Facilities | Industry News | Laboratory Testing
NexPoint Acquires Mfg. Property for Kindeva Drug Delivery
R&D facility has clinical manufacturing and lab space offering a range of capabilities to support drug delivery solutions.01.16.24
-
Breaking News | Collaborations & Alliances | Drug Delivery | Fill/Finish | Industry News
FUJIFILM Diosynth, SHL Medical Partner on Autoinjector Medicines
Aims to streamline processes and enhance efficiency for pharma and biotech companies offering self-injection device finished goods services.01.09.24
-
Breaking News | Drug Delivery | Industry News
Biora BioJet Delivery Platform Meets Key Performance Milestones
BioJet device exceeded performance targets for delivery of collaborator AstraZeneca’s molecule in preclinical study.01.02.24
-
Breaking News | Collaborations & Alliances | Drug Delivery | Drug Development
Biora Therapeutics Unveils Research Collaboration for BioJet Platform
Agreement provides funding to test BioJet platform’s ability to achieve bioavailability through oral delivery of molecules.12.11.23
-
Breaking News | Drug Delivery | Industry News
Kindeva, Orbia Partner on Low GWP Propellant Conversion
Aims to facilitate conversion of pMDI products to the lower GWP propellent 152a and progress them through clinical development.12.05.23
-
APIs | Breaking News | Collaborations & Alliances | Drug Delivery
Hovione, IDC Partner on Nasal Powder Delivery Device
New active nasal powder delivery devices are designed to enable broad and targeted nasal deposition flexibility11.29.23
-
Drug Delivery
-
Drug Delivery
Contracting & Outsourcing 2023: Q&A with Mike Ratigan of Kindeva Drug Delivery
Vice President of Business Development provides insight on outsourcing and drug delivery trends, and successful partnerships.Videos11.16.23
-
Breaking News | Collaborations & Alliances | Drug Delivery | Drug Development
Ethris, Heqet Partner on RNA-based Heart Disease Therapeutics
Heqet to lead program development and Ethris will provide its Stabilized NanoParticle (SNaP) LNP platform to deliver ncRNA payloads.11.13.23
-
Breaking News | Drug Delivery | Drug Development | Trials & Filings
FDA Grants Orphan Drug Status to MAIA's Glioblastoma Drug
Third ODD granted to THIO, including for hepatocellular carcinoma and small cell lung cancer.11.10.23
-
Breaking News | Drug Delivery | Drug Development | Drug Discovery | Trials & Filings
FDA Approves Takeda’s ADZYNMA for cTTP
Phase 3 trial data showed efficacy, pharmacokinetic, safety and tolerability.11.10.23
